General News
Expert Okays GSK’s Sale of Ribena, Lucozade to Suntory
GlaxoSmithKline’s sale of Ribena and Lucozade to Japan’s Suntory Beverage & Food Ltd completes a transition for GlaxoSmithKline that started in the second half of the 20th century.
Christian Stadler, Warwick Business School associate professor of Strategic Management, Christian Stadler, analysis of the deal made available to Nigeria CommunicationsWeek said that “I don’t think it is a sign that Ribena and Lucozade have been doing badly, rather that they are really consumer goods, which are more suited to a pure consumer company that operates in that market, like Suntory”
Stadler has researched GlaxoSmithKline for his book “Enduring Success”, which looks at how long-living corporations have survived for so long.
Stadler said: “This is a question of how do you structure your portfolio, and I think this is a good idea for GlaxoSmithKline. A company is constantly assessing its portfolio and research shows that diversification into related products is best for profit. The big question for any company, though, is what are related products? And GlaxoSmithKline have decided that their core business should be in prescription drugs and consumer healthcare brands such as Panadol and Aquafresh rather than consumer goods.
“Looking at GlaxoSmithKline’s long history, since New Zealander Joseph Edward Nathan founded what was to become Glaxo Laboratories in 1861, it started out producing milk powder while Ribena was launched in the 1930s, and Lucozade in the 1920s, but the sale of them today completes a transition for GlaxoSmithKline that started in the second half of the 20th century”
According to the Professor, iIt has moved further and further into the prescription drug market and that is now its core business, with healthcare products added alongside them.
“I don’t think it is a sign that Ribena and Lucozade have been doing badly, rather that they are really consumer goods, which are more suited to a pure consumer company that operates in that market, like Suntory. By having a wider diversity you increase the complexity to manage the company, so by focusing more on prescription drugs and healthcare products it will make it easier to run the company” he added
Japan’s Suntory Beverage & Food Ltd was reported to have bought GlaxoSmithKline’s Lucozade and Ribena brands for 1.35 billion pounds to help the Japanese company expand into new markets.
The acquisition, announced by the companies on Monday, had been widely anticipated since people close to the process said last week that Suntory was in advanced talks on a deal that would preempt an auction of the iconic British drinks.
Japan’s second-largest drinks maker has plenty of cash after an initial public offering in June that raised four billion dollars.
It was always seen as the most likely buyer for the brands after GSK announced plans in April for their disposal.
Lucozade and Ribena are well-loved in Britain, but lack global reach, especially in the big emerging markets that are becoming the focus of the British drug maker’s consumer health business.
For Suntory, however, they offer a growth opportunity to counter sluggish demand at home. Suntory bought the Orangina Schweppes drinks brand for more than three billion dollars in 2009, giving it a significant presence in France and Spain.
By acquiring a new business with a focus on Britain, Suntory said it expected to further grow sales. The purchase also allows the Japanese group to extend its reach into countries where GSK already operates, such as Nigeria and Malaysia.
Despite being on the market for around 80 years, Lucozade and Ribena have combined annual sales of just over 500 million pounds a year.
That puts the transaction on a multiple of 2.7 times revenue – at the high end of recent soft drinks deals.
Suntory, which is better known for its beer and Yamazaki whisky, said the deal would have a limited effect on 2013 results and it was “currently examining the effect it will have on the performance outlook for the following business year and onward”.
The sale is expected to be completed by the end of the year, subject to regulatory approvals. For GSK, it will yield net proceeds of around 1.3 billion pounds – after tax, fees and costs – that will be used to reduce debt and for general corporate purposes.
The net gain will be excluded from 2013 core operating profit and earnings per share.
A GSK spokesman said Suntory’s bid was also attractive because it would protect jobs in Britain. Some 700 employees will transfer to the Japanese group, including around 500 workers at GSK’s Coleford factory in the west of England.
The GSK spokesman said there was expected to be very little, if any, impact on jobs as a result of the sale.
General News
More 14m Farmers to Benefit from AfDB-backed Initiative

Additional 14 million farmers in 37 low-income and vulnerable countries served by the African Development Fund, the Bank Group’s concessional financing window, are set to benefit from a technology initiative targeted at scaling up climate-resilient food production across the continent.

This comes after the African Development Bank Group (AfDB) and the International Institute of Tropical Agriculture (IITA) signed a $16.61 million grant agreement to launch the third phase of the Technologies for African Agricultural Transformation Programme (TAAT-III)
TAAT-III, funded by the African Development Fund, is expected to consolidate earlier gains benefiting 14 million more farmers while introducing a more sustainable, private sector-driven delivery approach.
AfDB said the initiative aims to reinforce seed and technology distribution systems, deepen partnerships with governments and agribusinesses, and expand the digital tools, including its technology e-catalogues and real-time monitoring platforms, to speed up deployment of high‑impact solutions.
Simeon Ehui, director general of IITA, commented: “TAAT-III allows us to deepen the delivery of science‑based solutions that improve farmers’ yields and livelihoods. Working with the Bank and our partners, we are scaling technologies that make Africa’s food systems more resilient and competitive.”
Since its launch in 2018, TAAT has become one of Africa’s most effective and transformative platforms for agricultural innovation, reaching nearly 25 million farmers and boosting productivity across major staples.
The initiative has expanded climate-resilient agricultural practices across over 35 million hectares.
In a statement, the AfDB said working closely with the Consultative Group of International Agricultural Research Centres and national and regional partners, TAAT has increased crop yields up to 69% and generated more than $4 billion in additional agricultural value.
Countries including Sudan, Ethiopia, Zambia, Zimbabwe, and Nigeria have recorded notable gains in staple crop productivity and resilience to climate shocks.
Nigeria has been a key beneficiary of TAAT initiatives. Under its Wheat Compact, farmers adopting improved heat-tolerant varieties more than doubled yields from 1.7 tons per hectare to 3.5 tons per hectare.
Programme supported seed system assessments also helped inform national reforms to expand access to certified, climate-resilient seeds.
Speaking at the signing ceremony, Abdul Kamara, director general of the Bank Group’s Nigeria Country Department, said the new phase will focus on scaling innovation more rapidly
Kamara said: “TAAT-III underscores the Bank’s commitment to ensuring that proven, climate-resilient agricultural technologies reach farmers faster and at scale. This phase strengthens the systems that deliver innovation, helping countries boost productivity, enhance resilience, and align agricultural transformation efforts with the Bank’s four new areas of emphasis, dubbed the Four Cardinal Points.”
General News
Newmark Webinar Explores How AI Could Transform Healthcare in Africa

A recent webinar hosted by the Newmark Group examined how Artificial Intelligence AI is changing healthcare across Africa, highlighting both its promise and its risks.

Newmark
The session, titled “AI in Healthcare: Opportunities and Challenges,” brought together healthcare and communications experts who agreed that AI can help fix long-standing problems in Africa’s health systems — but only if it is used carefully and responsibly.
Gilbert Manirakiza, CEO of Newmark Group in his opening speech said that AI is already helping speed up decision-making. He said AI tools can quickly analyse patient feedback, monitor conversations online, personalise health messages for different audiences and reduce delays in approvals.
He noted that many patients now turn to AI tools like ChatGPT to ask about symptoms and treatments. Because of this, he said health communicators must take responsibility for ensuring accurate information is available.
“If AI makes mistakes in healthcare, the consequences affect real lives,” he said.
Manirakiza stressed that Africa’s healthcare environment is unique. Many communities rely on mobile phones, speak different local languages and trust religious or community leaders. He warned that AI systems built mainly with Western data may misunderstand African realities.
He summarised his position simply: AI should help speed up work, but humans must ensure accuracy.
Daniel Marfo spoke about how AI is already being used in practical ways. Insurance companies now use AI systems to process thousands of claims daily. In hospitals, electronic medical records can suggest possible diagnoses and help doctors decide which patients need urgent attention.
He also said AI tools are helping detect problems in X-rays and MRI scans faster, especially in places where there are few radiologists. This reduces waiting time for patients.
At a national level, countries such as Rwanda, Sierra Leone and Ghana are building health data centres powered by AI to help governments track diseases and plan better responses.
However, Marfo warned that AI tools must be built using local medical guidelines to gain doctors’ trust. He emphasised that AI should support doctors, not replace them.
Dr. Afriyie Bempah focused on how AI can help countries prepare for health crises before they happen. He said resilience is not just about recovering from shocks, but about predicting them early.
He cited examples such as Kenya using AI to track mosquito patterns to predict malaria outbreaks, and Ghana using digital tools to improve disease reporting. In South Africa, digital health systems have been adapted to manage patients with chronic illnesses remotely.
He explained that linking clinics, pharmacies and supply chains through data sharing can help detect disease trends early and prevent large outbreaks.
During the question session, speakers discussed challenges such as data privacy, incorrect AI outputs, biased systems, and resistance from some healthcare workers.
They recommended clear rules for AI use, fact-checking AI-generated information, and creating internal review teams to monitor its application.
In their closing remarks, the panel encouraged healthcare professionals to learn how to work with AI tools to improve efficiency. They also urged young Africans to see healthcare technology as a major opportunity for innovation and investment.
The webinar concluded that AI is here to stay in healthcare. But its success in Africa will depend on strong regulation, local adaptation and continued human oversight — especially in a sector where mistakes can cost lives.
General News
Conoil Bonanza Winners Emerge

Conoil Plc is spreading joy this Valentine season as the first group of winners in its Valentine Bonanza promotion have been announced and rewarded. Launched on February 14, the campaign continues to delight customers at participating retail outlets.

The initial raffle draw, conducted on February 21, saw fortunate customers receive ₦10,000 worth of free petrol each. The draw was carried out publicly, with media representatives present to ensure full transparency. With the promotion still ongoing, more customers have the opportunity to join in and potentially be among the next winners.
A Conoil Management spokesperson explained that the initiative is a way to show appreciation to loyal customers for their ongoing support. “Our customers have responded impressively to the bonanza, with strong participation recorded across our stations,” the spokesperson said.
The second and final phase of the promotion is now in motion. Customers who purchase at least 10 litres of petrol at any participating Conoil station remain eligible to win in the grand finale raffle.
The grand finale is set for February 28 at 12 noon. Motorists in Lagos and Ogun states are encouraged to visit Conoil outlets to collect their tickets and take part in the exciting conclusion of this Valentine celebration.
Telecom3 days agoTelecom Giant MTN Injects N1.0 Trillion CAPEX into Network Expansion
E-Financial3 days agoHistory is Watching: Tinubu’s Moment to Rescue Nigeria’s Stolen Future
News3 days agoNITDA Equips Federal Character Commission with Data Tools to Drive Public Sector Reform
E-Business3 days agoKaspersky Discovers New Phishing Campaign Exploiting Google Tasks Notifications to Steal Corporate Credentials
Telecom2 days agoMTN Nigeria Posts Record N1.70 Trillion Pre‑Tax Profit, Declares N20 Dividend for 2025
General News2 days agoMore 14m Farmers to Benefit from AfDB-backed Initiative
Telecom2 days agoDimension Data Nigeria Secures ₦20Billion Funding to Strengthen Digital Infrastructure
Telecom2 days agoAlerzo Liquidates Delivery Fleet as N4.38bn Moniepoint Loan Row Deepens















